These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25816821)

  • 1. Use of value of information in UK health technology assessments.
    Mohiuddin S; Fenwick E; Payne K
    Int J Technol Assess Health Care; 2014 Dec; 30(6):553-70. PubMed ID: 25816821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of value of information: best informing research design and prioritization using current methods.
    Eckermann S; Karnon J; Willan AR
    Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis.
    Koffijberg H; Knies S; Janssen MP
    Value Health; 2018 Feb; 21(2):203-209. PubMed ID: 29477402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
    Rothery C; Strong M; Koffijberg HE; Basu A; Ghabri S; Knies S; Murray JF; Sanders Schmidler GD; Steuten L; Fenwick E
    Value Health; 2020 Mar; 23(3):277-286. PubMed ID: 32197720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
    Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S
    Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research.
    Oostenbrink JB; Al MJ; Oppe M; Rutten-van Mölken MP
    Value Health; 2008 Dec; 11(7):1070-80. PubMed ID: 19602213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
    Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
    Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.
    Basu A; Meltzer D
    Med Decis Making; 2018 May; 38(4):427-438. PubMed ID: 29529923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the international use of health technology assessments: exploring the merits of different methods when applied to the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme.
    Wright D; Milne R; Price A; Tose N
    Int J Technol Assess Health Care; 2013 Apr; 29(2):192-7. PubMed ID: 23552058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports.
    Taylor RS; Elston J
    Health Technol Assess; 2009 Jan; 13(8):iii, ix-xi, 1-50. PubMed ID: 19203465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Value of Information Calculation Using a Nonparametric Regression Approach: An Applied Perspective.
    Tuffaha HW; Strong M; Gordon LG; Scuffham PA
    Value Health; 2016 Jun; 19(4):505-9. PubMed ID: 27325343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of information analysis for a new technology: computer-assisted total knee replacement.
    Dong H; Coyle D; Buxton M
    Int J Technol Assess Health Care; 2007; 23(3):337-42. PubMed ID: 17579936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing value of information analyses.
    Janssen MP; Koffijberg H
    Value Health; 2009 Sep; 12(6):935-41. PubMed ID: 19432841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.
    Kim DD; Guzauskas GF; Bennette CS; Basu A; Veenstra DL; Ramsey SD; Carlson JJ
    Pharmacoeconomics; 2020 Feb; 38(2):171-179. PubMed ID: 31631254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Information in Asia: Concepts, Current Use, and Future Directions.
    Dilokthornsakul P; McQueen RB; Chaiyakunapruk N; Spackman E; Watanabe JH; Campbell JD
    Value Health Reg Issues; 2016 May; 9():99-104. PubMed ID: 27881269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic and critical review of the evolving methods and applications of value of information in academia and practice.
    Steuten L; van de Wetering G; Groothuis-Oudshoorn K; Retèl V
    Pharmacoeconomics; 2013 Jan; 31(1):25-48. PubMed ID: 23329591
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.